Mycozyl HC TOLNAFTATE HYDROCORTISONE PURETEK CORPORATION FDA Approved Each gram of Mycozyl HC™ contains 6.67 mg of hydrocortisone and 10 mg of tolnaftate in a vehicle consisting of: Apple Cider Vinegar, Argania Spinosa (Argan) Kernel Oil, Benzyl Alcohol, DL-Alpha-Tocopheryl Acetate, DMSO (Dimethyl Sulfoxide), Eucalyptus Globulus (Eucalyptus) Leaf Oil, Glycerin, Laureth-4, Lavandula Angustifolia (Lavender) Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, PEG-8. Chemically, hydrocortisone is [Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11ß)-], with the molecular formula C21H30O5 and molecular weight 362.47 and is represented by the following structural formula: Chemically, tolnaftate molecular formula is C19H17NOS and molecular weight 314.5 and is represented by the following structure formula: Structure Structure
FunFoxMeds bottle
Substance Hydrocortisone
Route
TOPICAL
Package NDC

Drug Facts

Composition & Profile

Strengths
30 ml
Quantities
30 ml
Treats Conditions
Indications And Usage Mycozyl Hc Is Indicated For Treatment Of Fungal Infection Of The Skin Skin Around The Nail And For The Relief Of Inflammatory And Pruritic Manifestations Of Corticosteroid Responsive Dermatoses

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UPC
0359088264034
UNII
WI4X0X7BPJ 06KB629TKV
Packaging

HOW SUPPLIED: Mycozyl HC™ is supplied in a 1 fl. oz. / 30 mL glass bottle with a screw cap fitted with a brush applicator ( NDC 59088-264-03) Store at 20º-25ºC (68º-77ºF) [see USP Controlled Room Temperature]. Protect from freezing and excessive heat. Keep container tightly closed. Use under the direction of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . Manufactured by: PureTek Corporation Panorama City, CA 91402 For questions or information call toll-free: 877-921-7873; Mycozyl HC™ Label

Package Descriptions
  • HOW SUPPLIED: Mycozyl HC™ is supplied in a 1 fl. oz. / 30 mL glass bottle with a screw cap fitted with a brush applicator ( NDC 59088-264-03) Store at 20º-25ºC (68º-77ºF) [see USP Controlled Room Temperature]. Protect from freezing and excessive heat. Keep container tightly closed. Use under the direction of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . Manufactured by: PureTek Corporation Panorama City, CA 91402 For questions or information call toll-free: 877-921-7873
  • Mycozyl HC™ Label

Overview

Each gram of Mycozyl HC™ contains 6.67 mg of hydrocortisone and 10 mg of tolnaftate in a vehicle consisting of: Apple Cider Vinegar, Argania Spinosa (Argan) Kernel Oil, Benzyl Alcohol, DL-Alpha-Tocopheryl Acetate, DMSO (Dimethyl Sulfoxide), Eucalyptus Globulus (Eucalyptus) Leaf Oil, Glycerin, Laureth-4, Lavandula Angustifolia (Lavender) Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, PEG-8. Chemically, hydrocortisone is [Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11ß)-], with the molecular formula C21H30O5 and molecular weight 362.47 and is represented by the following structural formula: Chemically, tolnaftate molecular formula is C19H17NOS and molecular weight 314.5 and is represented by the following structure formula: Structure Structure

Indications & Usage

: Mycozyl HC ™ is indicated for treatment of fungal infection of the skin, skin around the nail, and for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

: Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) paying special attention to the edges of the nail, cuticles, and skin around the nails or as directed by a doctor.

Warnings & Precautions
WARNINGS: For External Use Only. Not For Ophthalmic Use
Contraindications

: This product is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →